Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective
- Authors: Drenichev M.1, Borokh V.1
-
Affiliations:
- Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
- Issue: Vol 31, No 6 (2024)
- Pages: 671-682
- Section: Anti-Infectives and Infectious Diseases
- URL: https://rjpbr.com/0929-8673/article/view/645171
- DOI: https://doi.org/10.2174/0929867330666230420152130
- ID: 645171
Cite item
Full Text
Abstract
Adenosine and its analogues play an important role as bioregulators of metabolic processes in animal cells, affecting a variety of metabolic functions by acting through the purinergic signaling system. Synthesis and structure-activity relationship for some known purine nucleosides bearing chiral substituents are considered in this work. These compounds represent a promising potential as drug prototypes for targeted therapy of cancer, metabolic dysfunctions, and neuronal disorders due to their enhanced selectivity to receptors of the purinergic signaling system. Derivatives of adenosine and guanosine containing a chiral substituent also manifest antiviral activity.
About the authors
Mikhail Drenichev
Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Author for correspondence.
Email: info@benthamscience.net
Valentina Borokh
Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: info@benthamscience.net
Supplementary files
